Synopsis : – Sun Pharmaceutical Industries Limited announced that one of its wholly owned subsidiaries…
Tag:
agency
-
-
SYNOPSIS: The UN health agency said the Covid strain first discovered in southern Africa was…
-
ChemIntelligence
Rotam Expands Into New Markets with JOYA Herbicide Featuring Flumioxazin 51%.
by adminSUMMARY: Rotam, a global leader in superior crop protection products, announces the launch of JOYA™,…
-
Ronapreve & Regkirona
EMA Recommends Authorisation of Two Monoclonal Antibody Medicines Ronapreve & Regkirona for Covid-19
by adminTwo monoclonal antibody medicines for treating COVID-19 have been recommended for authorisation by the European…
-
ChemIntelligence
Sun Pharma Plans to Launch Merck’s Covid pill Molnupiravir Under the Brand Name Molxvir® in India Soon.
by adminKEYPOINTS Sun Pharmaceutical Industries is getting set to bring out its version of molnupiravir, the…
-
AstraZenecaDapagliflozin
NICE issues Draft Recommendation for AstraZeneca`s Forxiga (Dapagliflozin) to Treat Adults with Chronic Kidney Disease
by adminAbstract: The National Institute for Health and Care Excellence (NICE) has issued an Appraisal Consultation…
-
ChemIntelligence
Novavax partner of Serum Institute of India Receives Emergency Use Authorization for COVID-19 Vaccine (COVOVAX) in Indonesia.
by adminKEYPOINTS: Novavax Inc and partner Serum Institute of India said on Monday they received emergency…
-
Iptacopan
Novartis Pharmaceuticals UK awarded an Innovation Passport for Investigational Oral Therapy Iptacopan (LNP023)
by adminSUMMARY: Iptacopan has been awarded the Innovation Passport for the treatment of C3 glomerulopathy (C3G)…
-
Novartis
Novartis’s BLA has been accepted by US FDA & EMA for Kymriah (Tisagenlecleucel) to treat patients with relapsed or refractory follicular lymphoma.
by adminNovartis says that the U.S. and European regulators have accepted its marketing applications for CAR-T…
-
Active Pharmaceutical Ingredients (API)Ataluren
ANVISA grants expanded Approval to PTC’s Translarna label to include Ambulatory Patients as young as 2 years old in Brazil.
by adminKeypoints: PTC Therapeutics, Inc. announced that the Brazilian National Health Surveillance Agency has approved the…
Newer Posts